StonvexLoading…
StonvexStonvexStonvexCore line items from IRTC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $747.14M | $591.84M | $492.68M | $410.92M |
Operating Income | $-57.41M | $-115.50M | $-125.16M | $-113.78M |
Net Income | $-44.55M | $-113.29M | $-123.41M | $-116.16M |
EPS (Diluted) | $-1.39 | $-3.63 | $-4.04 | $-3.88 |
Total Assets | $1.02B | $931.45M | $433.14M | $448.22M |
Total Liabilities | $867.30M | $840.54M | $223.05M | $208.41M |
Cash & Equivalents | $236.01M | $419.60M | $36.17M | $78.83M |
Free Cash Flow OCF − CapEx | $34.52M | $-30.55M | $-90.53M | $-52.84M |
Shares Outstanding | 32.30M | 31.39M | 30.95M | 30.19M |